Medicare Part D coverage · celecoxib · RxCUI 2373460
celecoxib 25 MG/ML Oral Solution [Elyxyb]
Per the CMS 2026 Part D formulary file, celecoxib 25 MG/ML Oral Solution [Elyxyb] is covered by 11 Medicare Part D plans (0.2% of enrollable products), averaging Tier 3, with prior authorization required on 50% of covering formularies.
- 0.2%
- Plan coverage
- 11
- Plans covering
- T3
- Avg tier
- 50%
- Prior auth required
What the CMS Formulary Data Shows for celecoxib 25 MG/ML Oral Solution [Elyxyb]
Per the CMS 2026 Part D formulary file, celecoxib 25 MG/ML Oral Solution [Elyxyb] (RxNorm concept RXCUI 2373460, generic name celecoxib) appears on 2 distinct formulary files spanning 11 Medicare Part D plan offerings - 0.2% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 2 to Tier 4, with a cross-plan average of Tier 3.
Real-world access to celecoxib 25 MG/ML Oral Solution [Elyxyb] depends on utilization management as much as tier placement: 50% of covering formularies require prior authorization. 0% require step therapy. 50% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 1,627,703 Part D beneficiaries filled celecoxib 25 MG/ML Oral Solution [Elyxyb] in 2023, with total plan-and-beneficiary spending of $198,044,859 and an average per-beneficiary annual cost of $121.67. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry celecoxib 25 MG/ML Oral Solution [Elyxyb] today.
Coverage Details
- Formularies covering
- 2
- Plans covering
- 11
- Coverage rate
- 0.2%
- Tier range
- Tier 2 – Tier 4
- Average tier
- Tier 3, Preferred Brand
Restrictions
- Prior authorization required
- 50% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 50% of formularies
2023 Medicare Spending
- Beneficiaries
- 1,627,703
- Total spending
- $198,044,859
- Avg per beneficiary
- $121.67
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering celecoxib 25 MG/ML Oral Solution [Elyxyb]
11 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| CalOptima Health OneCare Complete (HMO D-SNP) | Orange County Health Authority | T2 | Yes | $0 | CA |
| Health First Rewards H1099-014 (HMO) | Health First Health Plans | T4 | No | $0 | FL |
| Health First SunSaver H1099-016 (HMO) | Health First Health Plans | T4 | No | $0 | FL |
| Health First Complete Care H1099-023 (HMO) | Health First Health Plans | T4 | No | $0 | FL |
| Health First Emerald Plus H1099-024 (HMO) | Health First Health Plans | T4 | No | $0 | FL |
| Health First Premier Access H1099-025 (HMO-POS) | Health First Health Plans | T4 | No | $0 | FL |
| Health First Emerald Plus H1099-026 (HMO) | Health First Health Plans | T4 | No | $0 | FL |
| Health First Premier Access H1099-027 (HMO-POS) | Health First Health Plans | T4 | No | $0 | FL |
| Health First Emerald Plus H1099-028 (HMO) | Health First Health Plans | T4 | No | $0 | FL |
| Health First Value H1099-006 (HMO) | Health First Health Plans | T4 | No | $15.00 | FL |
| Health First Classic H1099-001 (HMO-POS) | Health First Health Plans | T4 | No | $49.40 | FL |
Frequently Asked Questions
Is celecoxib 25 MG/ML Oral Solution [Elyxyb] covered by Medicare Part D?
Yes, celecoxib 25 MG/ML Oral Solution [Elyxyb] is covered by 11 Medicare Part D plans (0.2% of all Part D formularies).
What tier is celecoxib 25 MG/ML Oral Solution [Elyxyb] on Medicare Part D plans?
celecoxib 25 MG/ML Oral Solution [Elyxyb] averages Tier 3 across Part D plans, ranging from Tier 2 to Tier 4.
Does celecoxib 25 MG/ML Oral Solution [Elyxyb] require prior authorization?
50% of Part D formularies require prior authorization for celecoxib 25 MG/ML Oral Solution [Elyxyb]. Step therapy: 0%. Quantity limits: 50%.
How much does Medicare spend on celecoxib 25 MG/ML Oral Solution [Elyxyb]?
In 2023, total Medicare Part D spending on celecoxib 25 MG/ML Oral Solution [Elyxyb] was $198,044,859, covering 1,627,703 beneficiaries. The average spend per beneficiary was $121.67.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
Similar prior-authorization rate
- memantine hydrochloride 10 MG Oral Tablet 50% PA
- 0.2 ML adalimumab-atto 50 MG/ML Prefilled Syringe [Amjevita] 50% PA
- prednisolone 15 MG Disintegrating Oral Tablet [Orapred] 50% PA
- trazodone hydrochloride 10 MG/ML Oral Solution [Raldesy] 50% PA
- acetaminophen 325 MG / butalbital 50 MG Oral Tablet [Tencon] 50% PA
- methylprednisolone 8 MG Oral Tablet [Medrol] 50% PA